March 8, 2023
Marlborough, MASSACHUSETTS /March 8, 2023/PRNEWSWIRE/ -- Candela Corporation (Candela), a leading global medical aesthetic device company headquartered in Marlborough, MA, today announced that the PicoWay® laser system has received FDA clearance and Health Canada licensing for expanded indications, including …
Feb. 28, 2023
Marlborough, Massachusetts, Feb. 28, 2023 /PRNEWSWIRE/ -- Candela Corporation, a leading global medical aesthetic device company headquartered in Marlborough, MA, today announced Health Canada licensing and availability of the Nordlys™ multi-application platform featuring Selective Waveband Technology (SWT®) and …
Feb. 6, 2023
Correct, Maintain and Restore Skin with the Profound Matrix™ System. Radiofrequency. Intelligently Redefined.
Marlborough, Massachusetts, February 6, 2023 – Candela, the leading provider of energy-based solutions worldwide, and the pioneer of the first and only long-pulse radiofrequency (RF) microneedling …
Jan. 25, 2021
A 50-year legacy of innovation and a continued commitment to Science. Results. Trust.
MARLBOROUGH, MASS., Jan. 25, 2021 Candela, a leading global medical aesthetic device company, today announced the availability of the Frax Pro® system. The FDA-cleared, non-ablative fractional …
Jan. 14, 2021
Merz Aesthetics and Candela Corporation launch commercial collaboration creating broad medical aesthetics portfolio.
Committed to innovative customer solutions and meeting patient demand for full-spectrum of medical aesthetic treatment.
RALEIGH, N.C. – January 14, 2021 – In a unique commercial collaboration, …
June 17, 2020
The CO2RE laser platform offers women a nonsurgical, hormone-free treatment for genitourinary syndrome of menopause and stress urinary incontinence
MARLBOROUGH, MASSACHUSETTS, JUNE 17, 2020 – Candela Corporation, a leading global aesthetic device company, today announced that Health Canada …
Jan. 31, 2020
Candela to become the exclusive global commercial partner for the Exceed™ medical microneedling system of MT.DERM
MARLBOROUGH, Mass. and BERLIN, Jan. 31, 2020 /PRNewswire/ -- Candela Corporation, a leading global medical aesthetic device company, has entered into an exclusive collaboration …
July 16, 2019
Wayland, Mass. and Yokneam, Israel, July 16, 2019 -- Candela Corporation, a leading global aesthetic device company and the exclusive licensee of certain patents of General Hospital Corporation, d/b/a Massachusetts General Hospital, Lumenis Ltd., a global leader in the field …
May 5, 2019
30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the E.V.A. clinic’s-Vascular Birthmarks Foundation’s International Congress on Vascular Anomalies in Athens, Greece, June 7-8, 2019.
For the second year the Vascular Birthmark Foundation (VBF) organizes …
March 20, 2019
WAYLAND, Mass. and LAKE FOREST, Calif., March 20, 2019 /PRNewswire/ -- Syneron Medical Ltd. and Candela Corporation (collectively, "Candela"), a leading global aesthetic device company and the exclusive licensee of certain patents of General Hospital Corporation, d/b/a Massachusetts General Hospital …
March 14, 2019
JAMA-Dermatology publishes Dr. Roy Geronemus' authored largest study of infants and babies receiving a non-invasive treatment (vs. surgery) for birthmarks, port wine stains and other vascular related skin conditions on the face and body using the Vbeam laser system.
March 1, 2019
New brand reflects commitment to Science, Results, Trust
WAYLAND, MASSACHUSETTS, March 1, 2019 – Syneron-Candela, a leading global medical aesthetic device company, announced today that it has rebranded the company to Candela and will be unveiling new corporate branding at …
Nov. 12, 2018
WAYLAND, MASSACHUSETTS, NOVEMBER 12, 2018 – Candela Corporation, a leading global aesthetic device company, announces that the Profound® treatment has been named “New Treatment of the Year” by The Global Aesthetic Awards, a leading aesthetic industry award, also known …
Oct. 1, 2018
Syneron Candela Korea Co. Ltd focused on enhancing Customer Service in Growth Markets
WAYLAND, MASSACHUSETTS, October 1, 2018 - Syneron Candela announces the opening of Syneron Candela Korea Co Ltd, a new headquarters designed to support all commercial activities for …
Sept. 28, 2018
Over 30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the Vascular Birthmarks Foundation's 18th Annual Conference.
WAYLAND, Mass., Sept. 26, 2018 /PRNewswire/ -- Candela Corporation, a leading global manufacturer of energy-based devices, announces it …
Sept. 5, 2018
Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Candela’s portfolio, further strengthening their position in multi-application, multi-technology devices
WAYLAND, MASSACHUSETTS, September 5, 2018 – Candela Corporation, a leading global aesthetic device company, announces the acquisition of …
July 17, 2018
The new Vbeam Prima takes Candela’s “gold standard” 595 nm Pulsed Dye Laser (PDL) platform to the next level.
WAYLAND, MASSACHUSETTS, JULY 17, 2018 – Candela Corporation, a leading global aesthetic device company, announces the U.S. Food and Drug Administration …